Anixa Biosciences, Inc. (ANIX)

Anixa Biosciences Market Cap

Anixa Biosciences has a market cap or net worth of $83.15 million as of June 5, 2026. Its market cap has increased by 0.91% in one year.

• Market Cap: 83.15M
• Enterprise Value: 69.14M
• 1-Year Change: 0.91%
• Ranking: #4379
• Category: Micro-Cap
• Stock Price: $2.48

Market Cap Chart

Since December 1, 1998, Anixa Biosciences's market cap has decreased from $83.20M to $83.15M, a decrease of -0.06%. That is a compound annual growth rate of -0.00%.

Market Cap History

Date	Market Cap	% Change
Jun 5, 2026	83.10M	-19.08%
Dec 31, 2025	102.70M	37.48%
Dec 31, 2024	74.70M	-38.06%
Dec 29, 2023	120.60M	-7.44%
Dec 30, 2022	130.30M	46.40%
Dec 31, 2021	89.00M	21.92%
Dec 31, 2020	73.00M	10.11%
Dec 31, 2019	66.30M	-10.04%
Dec 31, 2018	73.70M	106.44%
Dec 29, 2017	35.70M	-24.52%
Dec 30, 2016	47.30M	79.85%
Dec 31, 2015	26.30M	10.04%
Dec 31, 2014	23.90M	-39.34%
Dec 31, 2013	39.40M	18.32%
Dec 31, 2012	33.30M	73.44%
Dec 30, 2011	19.20M	-39.81%
Dec 31, 2010	31.90M	-65.14%
Dec 31, 2009	91.50M	61.95%
Dec 31, 2008	56.50M	-63.00%
Dec 31, 2007	152.70M	62.27%
Dec 29, 2006	94.10M	31.24%
Dec 30, 2005	71.70M	-0.42%
Dec 31, 2004	72.00M	94.07%
Dec 31, 2003	37.10M	183.21%
Dec 31, 2002	13.10M	-52.88%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 5, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 6, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
MAIA Biotechnology	91.20M
Pelthos Therapeutics	89.88M
Rani Therapeutics Holdings	89.69M
ImmuCell	89.29M
OKYO Pharma	88.17M
Atara Biotherapeutics	87.42M
ProMIS Neurosciences	87.26M
Aardvark Therapeutics	85.96M